Intimation about Board Meeting scheduled to be held on January 28, 2017 to approve unaudited financial statements (both Stand-alone and Consolidated) for the quarter/nine months ended 31-12-2016, and consider paying interim dividend if any.
REACH US
Address: D37/1, MIDC-Turbhe, Navi Mumbai
Email: investor_relations@thyrocare.com
Tel: +9122 4125 2525 / 3090 0000
CIN – L85110MH2000PLC123882
ISIN – INE594H01019